Stay updated on AMV564 Study in AML Patients Clinical Trial
Sign up to get notified when there's something new on the AMV564 Study in AML Patients Clinical Trial page.

Latest updates to the AMV564 Study in AML Patients Clinical Trial page
- Check2 days agoChange DetectedA notice appears above the study record explaining that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the content while the site header and footer remain visible.SummaryDifference18%

- Check59 days agoChange DetectedThe page's revision indicator changed from v3.6.5 to v3.6.6, representing a small update to the page version. There are no indicated user-facing content changes in this update.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, indicating a minor version update. This change does not modify the study details or other substantive content.SummaryDifference0.1%

Stay in the know with updates to AMV564 Study in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMV564 Study in AML Patients Clinical Trial page.